Updating the Epidemiology of Blastomycosis and Histoplasmosis in the United States, Using National Electronic Health Record Data, 2013–2023
The Journal of Infectious Diseases · 20.12.2025 · 232 (6) · e1048-e1059
DOI: 10.1093/infdis/jiaf472 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 10.09.2025. Verfasst von Juliana G E Bartels und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Environmental Health Sciences, University of California, Berkeley, California, USA. Hauptthemen laut MEDLINE: Histoplasmosis, Blastomycosis, Electronic Health Records. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIOSH CDC HHS, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Background
Where surveillance data are limited, nationally representative electronic health records allow for geographic, temporal, and demographic characterization of the fungal diseases blastomycosis and histoplasmosis.
Methods
We identified incident blastomycosis and histoplasmosis cases from 2013 to 2023 within Oracle EHR Real-World Data, which comprises 1.6 billion healthcare encounters nationally. To characterize spatiotemporal incidence trends, we used generalized estimating equations weighted for nonrepresentativeness of electronic health record–reporting facilities. We computed standardized incidence rate ratios (sIRRs), which relay relative differences in standardized incidence rates between regions, race/ethnicity, gender, and age subgroups and the national population.
Results
National incidence rates in 2023 were 2.4 (95% confidence interval [CI]: 1.6–3.5) and 1.9 times (95% CI: 1.6–2.2) rates in 2013, for blastomycosis and histoplasmosis, respectively. Blastomycosis incidence rates among Hispanic or Latino and non-Hispanic Black individuals were 60% (sIRR: 1.6 [95% CI: 1.0–2.4]) and 30% (sIRR: 1.3 [95% CI: 1.0–1.6]) higher than the standardized national incidence rate. Histoplasmosis incidence rates were elevated among non-Hispanic White patients (sIRR: 1.05 [95% CI: 1.02–1.08]). Standardized incidence rates of both diseases were higher among older and male patients, were consistently elevated in the Upper Midwest and Ohio Valley regions, and increased greatly in the Northern Rockies and Plains from 2013 to 2023. We estimated high incidence in states (blastomycosis: Illinois, Kentucky, and West Virginia; histoplasmosis: Missouri, Iowa, and Oklahoma) that do not report to surveillance.
Conclusions
This analysis revealed increasing incidence rates of blastomycosis and histoplasmosis, with increasing diagnoses outside of historically endemic regions, and notable differences in incidence by race/ethnicity, gender, and age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Environmental Health Sciences, University of California, Berkeley, California, USA.
- Children's Mercy Research Institute, Kansas City, Missouri, USA.
- Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
- School of Letters and Sciences, University of California, Berkeley, Berkeley, California, USA.
- School of Science and Engineering, University of Missouri-Kansas City, Kansas City, Missouri, USA.
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Juliana G E Bartels, Simon K Camponuri, Brittany L Morgan Bustamante, Natalie J Kane, Rose M Reynolds, Aidan Lee, Mark A Hoffman, Theodore C White, Justin V Remais, Jennifer R Head
Förderung
- NIOSH CDC HHS
- NIH HHS
- NIAID NIH HHS
- National Institute
- National Institute of Allergy and Infectious Diseases
- CDC HHS
- National Institutes of Health
- Centers for Disease Control and Prevention
Zitieren
APA
Bartels, J. G. E., Camponuri, S. K., Snow, T. T., Bustamante, B. L. M., Kane, N. J., Reynolds, R. M., Lee, A., Hoffman, M. A., White, T. C., Remais, J. V., & Head, J. R. (2025). Updating the Epidemiology of Blastomycosis and Histoplasmosis in the United States, Using National Electronic Health Record Data, 2013–2023. The Journal of Infectious Diseases, 232(6), e1048-e1059. https://doi.org/10.1093/infdis/jiaf472
Vancouver
Bartels JGE, Camponuri SK, Snow TT, Bustamante BLM, Kane NJ, Reynolds RM, et al. Updating the Epidemiology of Blastomycosis and Histoplasmosis in the United States, Using National Electronic Health Record Data, 2013–2023. The Journal of Infectious Diseases. 2025;232(6):e1048-e1059. doi:10.1093/infdis/jiaf472
BibTeX
@article{Bartels2025,
author = {Bartels, Juliana G E and Camponuri, Simon K and Snow, Theo T and Bustamante, Brittany L Morgan and Kane, Natalie J and Reynolds, Rose M and Lee, Aidan and Hoffman, Mark A and White, Theodore C and Remais, Justin V and Head, Jennifer R},
title = {Updating the Epidemiology of Blastomycosis and Histoplasmosis in the United States, Using National Electronic Health Record Data, 2013–2023},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {232},
number = {6},
pages = {e1048--e1059},
doi = {10.1093/infdis/jiaf472}
}
EUVIMED